Background. Nucleophosmin 1 (NPM1) plays an important role in ribosomal synthesis and malignancies, but NPM1 mutations occur rarely in the blast-crisis and chronic-phase chronic myelogenous leukemia (CML) patients. This evidence concerns the gene NPM1 and chronic myelogenous leukemia, BCR-ABL1 positive.